Bone Health in Facioscapulohumeral Muscular Dystrophy: A Cross-Sectional Study
Authors
Chagarlamudi, HemaCorbett, Alastair
Stoll, Marion
Bibat, Genila
Grosmann, Carla
Stock, Carly Matichak
Stinson, Nikia
Shapiro, Jay
Wagner, Kathryn
UMass Chan Affiliations
Wellstone Center for FSHDDocument Type
Journal ArticlePublication Date
2017-02-18Keywords
Muscular DystrophyBone Density
Bone Health
Bone Mineral Density
Facioscapulohumeral Muscular Dystrophy (FSHD)
Cell Biology
Developmental Biology
Molecular Biology
Molecular Genetics
Musculoskeletal Diseases
Nervous System Diseases
Metadata
Show full item recordAbstract
INTRODUCTION: We provide a comprehensive overview of bone health in facioscapulohumeral muscular dystrophy (FSHD). METHODS: Ninety-four adult individuals with FSHD1 from two sites were included in this cross-sectional study. Clinical characteristics and determinants of bone health were examined. Relationships between bone mineral density (BMD), strength and function were explored. RESULTS: Nearly a third of subjects were deficient in vitamin D3. Mean whole body BMD z-score was -0.7; 11% had greater than age-related reductions in whole body BMD (z-score < -2.0). Whole body and regional BMD were associated with strength and function. Thirty-six percent had a history of fractures. Likelihood for fractures was reduced for those with normal whole body BMD (OR=0.25, 95% CI: 0.04-0.78). DISCUSSION: A diagnosis of FSHD is not necessarily predictive of reduced BMD or increased fracture rate. Given the considerable variability of bone health in the FSHD population, strength and function can serve as predictors of BMD. This article is protected by copyright.Source
Muscle Nerve. 2017 Feb 18. doi: 10.1002/mus.25619. Link to article on publisher's siteDOI
10.1002/mus.25619Permanent Link to this Item
http://hdl.handle.net/20.500.14038/50567PubMed ID
28214289Related Resources
Link to Article in PubMedae974a485f413a2113503eed53cd6c53
10.1002/mus.25619